Bupropion Hydrochloride/Dextromethorphan Hydrobromide

盐酸安非他酮/氢溴酸右美沙芬

Report date: 2026/05/07 20:00:36

Base Information

Drug NameBupropion Hydrochloride/Dextromethorphan Hydrobromide
Drug Alias NameDextromethorphan/Bupropion右美沙芬/盐酸安非他酮盐酸安非他酮右美沙芬Dextromethorphan Hydrobromide/Bupropion Hydrochloride右美沙芬盐酸安非他酮 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsDopamine reuptake inhibitorsAdrenergic receptors antagonists
TargetsGlutamate [NMDA] receptorDopamine transporterAdrenergic receptors
Therapy Area/IndicationsAgitationDepressive Disorder, Treatment-ResistantDepressive Disorder, Major +[7] 
Global Approved IndicationsDepressive Disorder
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/08/18
Country/TerritoryCanadaUnited StatesPuerto Rico +[5] 
CombinationsYes Bupropion HydrochlorideDextromethorphan Hydrobromide
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAntecip Bioventures
China Registration ClassN/A

Develop Information

Active CompaniesAxsome Therapeutics IncJiangsu Nhwa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAgitationDepressive Disorder, MajorDepressive Disorder +[5] 
Inactive IndicationsDepressive Disorder, Treatment-ResistantDepression

Other Information

ATC CodeN/A
Related LinksWikipedia